• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Biomedical researcher gets $1.9 million to study influenza vaccines and cross protective immunity

Bioengineer by Bioengineer
July 31, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Georgia State University

ATLANTA–Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has renewed a four-year, $1.9 million federal grant to develop influenza vaccines that offer enhanced protection against a broad range of influenza virus strains.

This is the second grant renewal from the National Institute for Allergy and Infectious Diseases of the National Institutes of Health. The project will explore novel approaches to improve the cross protective properties of licensed seasonal influenza vaccines, with results expected to be applicable to the clinic and have a significant impact on public health.

Dr. Richard Plemper, a professor in the Institute for Biomedical Sciences, will be a co-investigator for the research project.

Influenza, a contagious respiratory illness caused by influenza viruses, can cause mild to severe illness and even lead to death. Influenza vaccines, such as inactivated split virus vaccines and live attenuated influenza virus vaccines, that are based on immunity to the hemagglutinin (HA) hypervariable protein, do not provide effective cross protection against new influenza virus strains that develop through changes in the virus' genes as it replicates over time. Developing a novel vaccine that improves the efficacy and extent of cross protection is a high priority.

"With this project, we've proposed groundbreaking approaches to increase the capacity of current influenza vaccine platforms to give cross protection against new influenza virus strains," Kang said. "We will achieve this by incorporating M2e epitopes, which are found among all influenza strains, into HA and engineering a M2e-HA molecule."

This project has three aims. First, the researchers will test the hypothesis that recombinant seasonal inactivated split virus vaccines and live attenuated influenza virus vaccines with M2e-HA molecules will enhance the efficacy of cross protection by inducing immunity to M2e and HA.

Secondly, the research team will study recombinant influenza virus vaccines and investigate the role of cellular and humoral immune mechanisms in cross protection in mice. Lastly, the researchers will validate the efficacy of cross protection by recombinant influenza virus vaccines in ferrets, the most relevant small-animal model for the assessment of influenza vaccines, in collaboration with a team led by Dr. Ian York at the Centers for Disease Control and Prevention in Atlanta.

An abstract of the grant, 2R01AI093772-07A1, is available at NIH's Project RePORTer website.

For more information about the Institute for Biomedical Sciences, visit http://biomedical.gsu.edu.

###

Media Contact

LaTina Emerson
[email protected]
404-413-1353
@GSU_News

http://www.gsu.edu

Original Source

http://news.gsu.edu/2017/07/31/biomedical-study-flu-vaccines/

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Exploring Plastid Genome Traits in Saururaceae

October 5, 2025
blank

Exploring Splicing Patterns in Medicinal Rheum Palmatum

October 5, 2025

NR2E1 Gene Methylation Influences Beef Cattle Adipocytes

October 5, 2025

“Rice Cultivar Transcriptome Reveals Heat Stress Response Genes”

October 4, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    70 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Multimodal Language Models in Chemistry Research

Healthcare Workers’ Views on HIV and Non-Communicable Care

Supporting Caregivers of COPD Patients: Key Insights

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.